Concepedia

Hua Jiang

HJ

Statistics

Publications

3

Citations

61

H-Index

3

Active since

2022

Affiliations

First Affiliated Hospital of Anhui Medical University(Current)

Anhui Medical University

Xijing Hospital

Second Affiliated Hospital of Xi'an Jiaotong University

Air Force Medical University

Hua Jiang is an author at First Affiliated Hospital of Anhui Medical University specializing in oncology, monoclonal antibody technology, and monoclonal antibody therapy.

ORCID

Publications per year

2022–2023

3

Publications

3

Updated results of a phase I, open-label study of BCMA/CD19 dual-targeting fast CAR-T GC012F for patients with relapsed/refractory multiple myeloma (RRMM).

Juan Du, Weijun Fu, Hua Jiang et al. · Journal of Clinical Oncology · 2023 · 36 citations

, , +17

Updated results of a multicenter first-in-human study of BCMA/CD19 dual-targeting fast CAR-T GC012F for patients with relapsed/refractory multiple myeloma (RRMM).

Juan Du, Hua Jiang, Baoxia Dong et al. · Journal of Clinical Oncology · 2022 · 15 citations

, , +17

P869: UPDATED RESULTS OF A PHASE I, OPEN-LABEL STUDY OF BCMA/CD19 DUAL-TARGETING FASTCAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Juan Du, Weijun Fu, Hua Jiang et al. · HemaSphere · 2023 · 10 citations · Full text

, , +17

1–3 of 3